US 9765091
Tetrahydropyrazolo [3,4-b] azepine derivatives and their use as allosteric modulators of metabotropic glutamate receptors
granted A61KA61K31/429A61K45/06
Quick answer
US patent 9765091 (Tetrahydropyrazolo [3,4-b] azepine derivatives and their use as allosteric modulators of metabotropic glutamate receptors) held by Addex Pharma, S.A. expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Addex Pharma, S.A.
- Grant date
- Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/429, A61K45/06, A61K9/0019, A61K9/0095